MetLife Investment Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-14,651
| Closed | -$703K | – | 2413 |
|
|
2020
Q1 | $703K | Hold |
14,651
| – | – | 0.01% | 1052 |
|
|
2019
Q4 | $688K | Hold |
14,651
| – | – | 0.01% | 1284 |
|
|
2019
Q3 | $346K | Hold |
14,651
| – | – | ﹤0.01% | 1621 |
|
|
2019
Q2 | $441K | Buy |
14,651
+7,136
| +95% | +$215K | ﹤0.01% | 1556 |
|
|
2019
Q1 | $168K | Hold |
7,515
| – | – | ﹤0.01% | 2063 |
|
|
2018
Q4 | $137K | Buy |
+7,515
| New | +$137K | ﹤0.01% | 2128 |
|